Table 1 Clinical details

Gender (male/female)

22/27

15/14

4/7

3/6

18/19

Age, years (mean, range)

40 (19–71)

39 (22–62)

42 (20–63)

42 (19–58)

42 (26–63)

Age at diagnosis (≤25/> 25 years)

26/23

15/14

7/4

4/5

–

Years with disease (≤10/> 10 years)

27/22

16/13

6/5

5/4

–

HB-score (mean, range)

10 (6–18)^a

10 (6–18)^c

11 (8–15)

11 (5–15)^f

–

PDAI (mean, range)

10 (2–12)^b

9 (2–12)^d

10 (9–12)^e

7(6–9)^g

–

Extension (D, J, TI, IC, C)

1, 1, 17, 5, 35

0, 0, 9, 3, 23

0, 0, 6, 1, 7

1, 1, 2, 1, 5

–

Surgery (IR, IR + HC, HC, Co, IC + Co)

9, 1, 2, 9, 4

5, 0, 2, 5, 0

2, 1, 0, 2, 2

2, 0, 0, 2,2

–

Smoking/non-smoking

13/36

11/18

1/10

1/8

0/37

EIM (present/not present)

4/45

1/28

2/9

1/8

–

Steroids, n

–

Independent/dependent/responder/unknown

7/20/8/14

4/12/3/10

2/4/2/3

1/4/3/1

–

Daily medication, n

–

Systemic 5-aminosalicylic acid (1.6–3.2 g)

2

1

0

1

–

Topical 5-aminosalicylic acid (1 g)

0

0

0

0

–

Systemic glucocorticoids (75 mg)^h

9

6

2

1

–

Topical glucocorticoids (100 mg)

1

1

0

0

–

Azathioprine (100–150 mg)

29

18

7

4

–

Methotrexate (25 mg/wk)

1

0

0

1

–

None

15

9

4

2

37